CSL (CSLLY) News Today $80.05 -0.88 (-1.09%) As of 04/3/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period CSL (OTCMKTS:CSLLY) Reaches New 52-Week Low - Should You Sell?CSL (OTCMKTS:CSLLY) Hits New 52-Week Low - Here's What HappenedApril 1 at 5:35 PM | marketbeat.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Declines By 98.5%CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 300 shares, a decrease of 98.5% from the February 28th total of 20,000 shares. Based on an average daily trading volume, of 134,500 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company's stock are sold short.March 27, 2025 | marketbeat.comCSL Limited: Divergent Outlook For Its 2 Key BusinessesMarch 21, 2025 | seekingalpha.comCSL initiated with an Overweight at Morgan StanleyMarch 20, 2025 | markets.businessinsider.comCSL Recognized as One of Montreal's Top Employers for Seventh Consecutive YearMarch 18, 2025 | markets.businessinsider.comCSL Limited Announces Director’s Share AcquisitionMarch 16, 2025 | tipranks.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Expands By 189.9%CSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 20,000 shares, an increase of 189.9% from the February 13th total of 6,900 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 216,000 shares, the days-to-cover ratio is currently 0.1 days.March 14, 2025 | marketbeat.comCSL Limited Announces Cessation of SecuritiesMarch 12, 2025 | tipranks.comCSL Limited Updates Dividend Distribution DetailsMarch 12, 2025 | tipranks.comCSL Limited Issues Unquoted Equity Securities Under Employee Incentive SchemeMarch 11, 2025 | tipranks.comCSL Limited Announces Quotation of New Securities on ASXMarch 11, 2025 | tipranks.comCSL (OTCMKTS:CSLLY) Shares Up 2.4% - Time to Buy?CSL (OTCMKTS:CSLLY) Trading Up 2.4% - Here's WhyMarch 7, 2025 | marketbeat.comCSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE)February 20, 2025 | prnewswire.comCSL Limited Director Updates Shareholding PositionFebruary 19, 2025 | tipranks.comCSL Limited Issues Unquoted Equity Securities for Employee IncentiveFebruary 19, 2025 | tipranks.comEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 VaccineFebruary 14, 2025 | prnewswire.comEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 VaccineFebruary 14, 2025 | businesswire.comRBC Capital Remains a Hold on CSL (CMXHF)February 14, 2025 | markets.businessinsider.comCSL Limited Earnings Call Highlights Growth and ChallengesFebruary 13, 2025 | tipranks.comCSL (CMXHF) Receives a Buy from JardenFebruary 13, 2025 | markets.businessinsider.comEuropean Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)February 13, 2025 | prnewswire.comCSL Limited (OTCMKTS:CSLLY) Short Interest UpdateCSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 6,300 shares, a drop of 72.0% from the January 15th total of 22,500 shares. Based on an average trading volume of 163,300 shares, the days-to-cover ratio is currently 0.0 days.February 12, 2025 | marketbeat.comCSL (CMXHF) Gets a Buy from JefferiesFebruary 12, 2025 | markets.businessinsider.comCSL reports $2 billion profit for H1 FY2025 but needs a stronger second halfFebruary 12, 2025 | au.investing.comIs CSL undervalued after earnings season wobble?February 12, 2025 | morningstar.com.auCSL (CMXHF) Gets a Buy from Bell PotterFebruary 12, 2025 | markets.businessinsider.comCSL (OTCMKTS:CSLLY) Sets New 12-Month Low - Should You Sell?CSL (OTCMKTS:CSLLY) Sets New 52-Week Low - What's Next?February 11, 2025 | marketbeat.comCSL Limited (CSLLY) Q2 2025 Earnings Call TranscriptFebruary 11, 2025 | seekingalpha.comCSL lifts HY profit as plasma sales jump, offsets flu vaccine weaknessFebruary 11, 2025 | au.investing.comCSL war games manufacturing network in a world heading for trade warFebruary 11, 2025 | afr.comFalling US flu vaccine rates hurt Australia's CSL profit growthFebruary 11, 2025 | msn.comCSL shares tumble as vaccine unit misses expectationsFebruary 11, 2025 | msn.comCSL Behring confirms long-term efficacy of HEMGENIX in hemophilia B treatmentFebruary 7, 2025 | msn.comCSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia BFebruary 7, 2025 | prnewswire.comCarlisle (CSL) Q4 Earnings: What To ExpectFebruary 3, 2025 | msn.comCSL lays keel of seventh Anti-Submarine craft for Indian NavyJanuary 30, 2025 | msn.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Grows By 151.1%CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 31st total of 4,700 shares. Based on an average daily trading volume, of 159,800 shares, the days-to-cover ratio is presently 0.1 days.January 29, 2025 | marketbeat.comCSL Limited (CSLLY)January 25, 2025 | ca.finance.yahoo.comCSL Earns Fourth Consecutive Recognition as Top Employer for Young PeopleJanuary 21, 2025 | finance.yahoo.comHere's the earnings forecast out to 2029 for CSL sharesJanuary 20, 2025 | msn.comCSL (OTCMKTS:CSLLY) Upgraded by The Goldman Sachs Group to "Strong-Buy" RatingThe Goldman Sachs Group raised CSL to a "strong-buy" rating in a report on Thursday.January 18, 2025 | marketbeat.comWhy this top fundie has a 'loss of confidence' in CSL sharesJanuary 16, 2025 | msn.comGoldman Sachs initiates CSL stock with Buy rating on positive prospectsJanuary 16, 2025 | msn.comCSL Limited Announces Lapse of Conditional Securities RightsJanuary 13, 2025 | tipranks.comWhy did the CSL share price go backwards in 2024?January 5, 2025 | fool.com.auAEW Tag Team champs ‘Private Party’ join CSLJanuary 4, 2025 | sports.yahoo.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Increases By 683.3%CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 4,700 shares, a growth of 683.3% from the November 30th total of 600 shares. Based on an average daily trading volume, of 102,500 shares, the short-interest ratio is currently 0.0 days.December 26, 2024 | marketbeat.com3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu CasesDecember 23, 2024 | msn.comCSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE)December 13, 2024 | prnewswire.comCSL Limited Expands Market Presence with New SharesDecember 2, 2024 | tipranks.com Remove Ads Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address CSLLY Media Mentions By Week CSLLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSLLY News Sentiment▼-0.090.61▲Average Medical News Sentiment CSLLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSLLY Articles This Week▼12▲CSLLY Articles Average Week Remove Ads Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RHHBY News Today ABT News Today AZN News Today NVS News Today MRK News Today PFE News Today SNY News Today VRTX News Today BMY News Today GSK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CSLLY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CSLLY Stock Free CSLLY Stock Alerts